Adverse reactions in young children receiving the coronavirus disease 2019 vaccine.
Naomi MatsumotoJunya ShimizuYuji YokoyamaHirokazu TsukaharaTakashi YorifujiPublished in: Pediatrics international : official journal of the Japan Pediatric Society (2023)
This study provides valuable insight into the safety profile of the BNT162b2 vaccine in Japanese children aged 6 months to 4 years. Further research involving larger cohorts and appropriate control groups is needed.